Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4573126
Max Phase: Preclinical
Molecular Formula: C60H88N14O10
Molecular Weight: 1165.45
Molecule Type: Unknown
Associated Items:
ID: ALA4573126
Max Phase: Preclinical
Molecular Formula: C60H88N14O10
Molecular Weight: 1165.45
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)N(C)C(C)=O)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(N)=O
Standard InChI: InChI=1S/C60H88N14O10/c1-8-9-21-45(53(78)70-48(33-40-34-66-43-22-14-13-20-42(40)43)55(80)67-44(52(62)77)23-15-16-29-61)68-58(83)50(35(2)3)73-59(84)51(36(4)5)72-56(81)47(32-39-25-27-41(76)28-26-39)69-54(79)46(31-38-18-11-10-12-19-38)71-57(82)49(74(7)37(6)75)24-17-30-65-60(63)64/h10-14,18-20,22,25-28,34-36,44-51,66,76H,8-9,15-17,21,23-24,29-33,61H2,1-7H3,(H2,62,77)(H,67,80)(H,68,83)(H,69,79)(H,70,78)(H,71,82)(H,72,81)(H,73,84)(H4,63,64,65)/t44-,45-,46-,47-,48-,49-,50-,51-/m0/s1
Standard InChI Key: MLZQNNDQWVROFC-HTSIWFDASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1165.45 | Molecular Weight (Monoisotopic): 1164.6808 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Denèfle T, Pramil E, Gómez-Morales L, Levasseur MD, Lardé E, Newton C, Herry K, Herbi L, Lamotte Y, Odile E, Ancellin N, Grondin P, Martinez-Torres AC, Viviani F, Merle-Beral H, Lequin O, Susin SA, Karoyan P.. (2019) Homotrimerization Approach in the Design of Thrombospondin-1 Mimetic Peptides with Improved Potency in Triggering Regulated Cell Death of Cancer Cells., 62 (17): [PMID:31403795] [10.1021/acs.jmedchem.9b00024] |
Source(1):